Indivior PLC
INDV
ISIN GB00BN4HT335 / Valor 121550831
Indivior PLC
UMushroom community rating:
About company
Indivior PLC is a specialist pharmaceutical company that develops, manufactures and commercializes medications for addiction and related behavioral health disorders, with a primary focus on treatments for opioid use disorder. Its commercial portfolio centers on buprenorphine‑based products — notably the Suboxone film and the extended‑release injection Sublocade — and the company maintains global sales operations alongside a clinical development program aimed at improving treatment adherence and reducing opioid misuse. Headquartered in the UK with substantial U.S. operations, Indivior is publicly traded and generates most of its revenue from its addiction‑treatment products while continuing to pursue regulatory approvals and new formulations.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
4553 M
Market cap (USD)
1,911,177
Daily traded volume (Shares)
9.925 / 9.635
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
